Webb7 sep. 2024 · Details of the OPTIMISMM trial have been previously reported by Richardson et al ... Richardson PG, Crowley J, et al. Risk of progression and survival in multiple ...
Richardson PG, Siegel D, Vij R et al . Pomalidomide alone or in ...
WebbEl cáncer se origina cuando las células en alguna parte del cuerpo comienzan a crecer de manera descontrolada. Existen muchos tipos de cáncer, pero todos comienzan debido al crecimiento sin control de unas células anormales. El crecimiento de las células cancerosas es diferente al crecimiento de las células normales. Webb14 mars 2013 · [email protected] PMID: 23243282 PMCID: PMC4123324 DOI: 10.1182/blood-2012-08-450742 Abstract This phase 1 dose-escalation study determined the maximum tolerated dose (MTD) of oral pomalidomide (4 dose levels) administered on days 1 to 21 of each 28-day cycle in patients with relapsed and … hologram data
A phase 2 trial of lenalidomide, bortezomib, and …
WebbRichardson PG, Siegel DS, Vij R, et al. Pomalidomide alone or in combination with low-dose dexamethasone in relapsed and refractory multiple myeloma: a randomized phase 2 study. Blood. 2014;123(12):1826–1832. 6. Webb6 jan. 2016 · Richardson PG Siegel DS Vij R et al. Pomalidomide alone or in combination with low-dose dexamethasone in relapsed and refractory multiple myeloma: a randomized phase 2 study. Blood. 2014; 123: 1826-1832 View in Article Scopus (306) PubMed Crossref Google Scholar 9. Lonial S Dimopoulos M Palumbo A et al. Webb14 nov. 2016 · The availability of second-generation proteasome inhibitors (carfilzomib and ixazomib), immunomodulatory drugs (pomalidomide), histone deacetylase inhibitors … fatipliző sablon